Clinical Trial Update: Polysomnography Study of MK-6096 in Participants With Primary Insomnia (MK-6096-011) [Phase 2]

View source ↗

Summary

Phase 2 trial update for MK-6096 in adults with primary insomnia; study completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• MK-6096

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Primary Insomnia | Phase 2 | Status: COMPLETED | Results posted: 2016-06-15